1. A Case of Hodgkin Lymphoma in a Patient with a History of Bone Pain and an Initial Diagnosis of Chronic Osteomyelitis. Issue 3 (May 2015) Authors: Griguolo, Gaia; Mazzucchelli, Luca; Cavalli, Franco; Ceriani, Luca; Zucca, Emanuele; Stathis, Anastasios Journal: Tumori Issue: Volume 101:Issue 3(2015) Page Start: e99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas. Issue 1 (2nd January 2022) Authors: Pirosa, Maria C.; Zhang, Lu; Hitz, Felicitas; Novak, Urban; Hess, Dagmar; Terrot, Tatiana; Pascale, Mariarosa; Mazzucchelli, Luca; Bertoni, Francesco; Cavalli, Franco; Zucca, Emanuele; Stathis, Anastasios Journal: Leukemia & lymphoma Issue: Volume 63:Issue 1(2022) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma. Issue 11 (27th November 2021) Authors: Collins, Graham P.; Eyre, Toby A.; Schmitz-Rohmer, Debora; Townsend, William; Popat, Rakesh; Giulino-Roth, Lisa; Fields, Paul A.; Krasniqi, Fatime; Soussain, Carole; Stathis, Anastasios; Andjelkovic, Nebojsa; Cunningham, David; Mandic, Danijela; Radulovic, Sinisa; Tijanic, Ivan; Horowitz, Netanel... Journal: HemaSphere Issue: Volume 5:Issue 11(2021) Page Start: e656 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B‐cell lymphomas. Issue 1 (6th November 2020) Authors: Vannata, Barbara; Vanazzi, Anna; Negri, Mara; Liptrott, Sarah Jayne; Bartosek, Anna Amalia; Miani, Monica; Di Sanzo, Alessandro; Cavalli, Franco; Zucca, Emanuele; Stathis, Anastasios Journal: Hematological oncology Issue: Volume 39:Issue 1(2021) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenström's macroglobulinemia. Issue 5 (16th April 2022) Authors: Panayiotidis, Panayiotis; Tumyan, Gayane; Thieblemont, Catherine; Ptushkin, Vadim V.; Marin-Niebla, Ana; García-Sanz, Ramon; Le Gouill, Steven; Stathis, Anastasios; Bottos, Alessia; Hamidi, Habib; Katz, Pablo; Perretti, Thomas; Willis, Jenna C.; Buske, Christian Journal: Leukemia & lymphoma Issue: Volume 63:Issue 5(2022) Page Start: 1058 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bromodomain and Extra-Terminal domain inhibitors for lymphoid malignancies. Issue 4 (July 2019) Authors: Bertoni, Francesco; Stathis, Anastasios Journal: Current opinion in hematology Issue: Volume 26:Issue 4(2019:Jul.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study. Issue 4 (April 2016) Authors: Amorim, Sandy; Stathis, Anastasios; Gleeson, Mary; Iyengar, Sunil; Magarotto, Valeria; Leleu, Xavier; Morschhauser, Franck; Karlin, Lionel; Broussais, Florence; Rezai, Keyvan; Herait, Patrice; Kahatt, Carmen; Lokiec, François; Salles, Gilles; Facon, Thierry; Palumbo, Antonio; Cunningham, David; Z... Journal: Lancet Issue: Volume 3:Issue 4(2016) Page Start: e196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical activity of everolimus in relapsed/refractory marginal zone B‐cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group. (27th March 2014) Authors: Conconi, Annarita; Raderer, Markus; Franceschetti, Silvia; Devizzi, Liliana; Ferreri, Andrés J. M.; Magagnoli, Massimo; Arcaini, Luca; Zinzani, Pier Luigi; Martinelli, Giovanni; Vitolo, Umberto; Kiesewetter, Barbara; Porro, Elena; Stathis, Anastasios; Gaidano, Gianluca; Cavalli, Franco; Zucca, Em... Journal: British journal of haematology Issue: Volume 166:Number 1(2014:Jul.) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Correlation between PSA kinetics and PSMA‐PET in prostate cancer restaging: A meta‐analysis. (11th January 2019) Authors: Pereira Mestre, Ricardo; Treglia, Giorgio; Ferrari, Matteo; Pascale, Mariarosa; Mazzara, Calogero; Azinwi, Ngwa Che; Llado', Anna; Stathis, Anastasios; Giovanella, Luca; Roggero, Enrico Journal: European journal of clinical investigation Issue: Volume 49:Number 3(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. EP294/#883 Elimusertib, an oral ataxia telangiectasia and RAD3-related inhibitor, in advanced gynecologic cancers with DNA damage response defects. (4th December 2022) Authors: Tan, David S; Castonguay, Vincent; Cote, Gregory; Bono, Johann S De; El-Rayes, Bassel; Gabrail, Nashat; Iwasa, Satoru; Joerger, Markus; Jones, Robert; Sawyer, Michael B; Shapiro, Geoffrey I; Tan, Daniel; Merz, Claudia; Uttenreuther, Regina; Jeffers, Michael; Ferraldeschi, Roberta; Sharma, Neelesh... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗